Sigyn Therapeutics, Inc.

Sigyn Therapeutics, Inc.verified

SIGY

Price:

$2

Market Cap:

$3.21M

Sigyn Therapeutics, Inc. operates as a development-stage therapeutic technology company. It offers Sigyn Therapy, a blood purification technology to overcome the limitations of previous drugs and devices to treat life-threatening inflammatory disorders, including sepsis, the cause of hospital deaths. The company also engages in evaluating the Sigyn Therapy to address various therapeutic targets, including endotoxin; peptidoglycan and lipoteichoic acid; viral pathogens; hepatic toxins; CytoVesicles; and tumor necrosis factor alpha, interleukin-1 beta, and interleukin 6, which are pro-inflammatory cytokines. The company is headquartered in San Diego, California.

Industry

Biotechnology

IPO Date

2021-01-08

Stock Exchange

OTC

Ticker

SIGY

The Enterprise Value as of December 2025 (TTM) for Sigyn Therapeutics, Inc. (SIGY) is 5.94M

According to Sigyn Therapeutics, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 5.94M. This represents a change of -24.03% compared to the average of 7.82M of the last 4 quarters.

Sigyn Therapeutics, Inc. (SIGY) Historical Enterprise Value (quarterly & annually)

How has SIGY Enterprise Value performed in the past?

The mean historical Enterprise Value of Sigyn Therapeutics, Inc. over the last ten years is 4.81M. The current 5.94M Enterprise Value has changed 12.25% with respect to the historical average. Over the past ten years (40 quarters), SIGY's Enterprise Value was at its highest in in the March 2021 quarter at 71.10M. The Enterprise Value was at its lowest in in the December 2015 quarter at -326623.85.

Quarterly (TTM)
Annual

Average

4.81M

Median

2.49M

Minimum

-294428.05

Maximum

18.84M

Sigyn Therapeutics, Inc. (SIGY) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Sigyn Therapeutics, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 313.19%

Maximum Annual Enterprise Value = 18.84M

Minimum Annual Increase = -347.79%

Minimum Annual Enterprise Value = -294428.05

Quarterly (TTM)
Annual
YearEnterprise ValueChange
20246.38M153.48%
20232.52M24.08%
20222.03M-89.24%
202118.84M69.80%
202011.09M313.19%
20192.68M9.28%
20182.46M46.47%
20171.68M129.91%
2016729.56K-347.79%
2015-294428.05-209.00%

Sigyn Therapeutics, Inc. (SIGY) Average Enterprise Value

How has SIGY Enterprise Value performed in the past?

The current Enterprise Value of Sigyn Therapeutics, Inc. (SIGY) is greater than its 3-year, less than than its 5-year, and greater than its 10-year historical averages

3-year avg

3.64M

5-year avg

8.17M

10-year avg

4.81M

Sigyn Therapeutics, Inc. (SIGY) Enterprise Value vs. Peers

How is SIGY’s Enterprise Value compared to its peers?

Sigyn Therapeutics, Inc.’s Enterprise Value is less than Acrux Limited (9.34M), greater than ProtoKinetix, Incorporated (1.96M), less than AXIM Biotechnologies, Inc. (14.70M), less than Zelira Therapeutics Limited (6.18M), greater than RepliCel Life Sciences Inc. (2.20M), greater than HAVN Life Sciences Inc. (487.77K), greater than Therma Bright Inc. (2.90M), greater than Pharmadrug Inc. (3.04M), less than Core One Labs Inc. (6.48M), greater than IR-Med Inc. (3.81M),

Build a custom stock screener for Sigyn Therapeutics, Inc. (SIGY) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Sigyn Therapeutics, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Sigyn Therapeutics, Inc. (SIGY) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Sigyn Therapeutics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the Enterprise Value?

How can you use the Enterprise Value?

What is Sigyn Therapeutics, Inc.'s Enterprise Value?

What is the highest Enterprise Value for Sigyn Therapeutics, Inc. (SIGY)?

What is the 3-year average Enterprise Value for Sigyn Therapeutics, Inc. (SIGY)?

What is the 5-year average Enterprise Value for Sigyn Therapeutics, Inc. (SIGY)?

How does the current Enterprise Value for Sigyn Therapeutics, Inc. (SIGY) compare to its historical average?